Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Envoy Medical (COCH) Cost of Revenue (2022 - 2025)

Envoy Medical's Cost of Revenue history spans 4 years, with the latest figure at $211000.0 for Q4 2025.

  • Quarterly results put Cost of Revenue at $211000.0 for Q4 2025, up 144.51% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 111.93% YoY), and the annual figure for FY2025 was $874000.0, up 17.79%.
  • Cost of Revenue for Q4 2025 was $211000.0 at Envoy Medical, down from $405000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $497000.0 in Q2 2024 to a low of -$474000.0 in Q4 2024.
  • The 4-year median for Cost of Revenue is $222500.0 (2023), against an average of $213642.9.
  • Peak annual rise in Cost of Revenue hit 206.79% in 2024, while the deepest fall reached 302.56% in 2024.
  • Year by year, Cost of Revenue stood at $151000.0 in 2022, then soared by 54.97% to $234000.0 in 2023, then tumbled by 302.56% to -$474000.0 in 2024, then skyrocketed by 144.51% to $211000.0 in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $211000.0, $405000.0, and $234000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.